May 16, 2013 – The Centers for Medicare & Medicaid Services (CMS) is likely “to find itself the target of ... read more
May 14, 2013 — In a Medical Marketing and Media (MMM) column posted May 1, Coalition for Healthcare Communication Executive ... read more
May 14, 2013 — The FDA’s Office of Prescription Drug Promotion (OPDP) will be holding an Enforcement Webinar May 16, ... read more
May 6, 2013 — With Sunshine Act reporting slated to begin in less than three months, it is sobering to ... read more
April 29, 2013 – Although the Digital Advertising Alliance (DAA) has made great strides to protect consumers’ privacy online – ... read more
April 22, 2013 – In April 18 comments to the Centers for Medicare & Medicaid Services (CMS) the Coalition for ... read more
April 4, 2013 – A new White Paper, “FDA Communications Oversight in a Digital Era,” issued April 2 by Eye ... read more
April 4, 2013 — Headlines run by news outlets regarding the status of industry-physician relationships rarely focus on the benefits ... read more
April 1, 2013 – By John Kamp, Executive Director, Coalition for Healthcare Communication While not directly about communication and marketing, ... read more
March 22, 2013 – Although spending on drug promotion has declined in recent years, 2013 could be a pivotal year ... read more
March 19, 2013 – Although the FDA has not yet issued its long-awaited social media guidance for the biopharma industry, ... read more
March 11, 2013 – Healthcare industry collaborations with physicians and researchers have “been at the heart of most of the ... read more
March 4, 2013 – A recent study released by the National Bureau of Economic Research (NBER) states that although consumer-directed ... read more
Feb. 25, 2013 – The Centers for Medicare & Medicaid (CMS) launched its “OPENPAYMENTS” Website last week, which will be ... read more
On Feb. 1, the Centers for Medicare & Medicaid Services (CMS) issued a final rule implementing the Sunshine Act provisions ... read more
Many Questions Still Unresolved Feb. 4, 2013 – Although the final rule to implement the Sunshine provisions of the Affordable ... read more
Jan. 15, 2013 – If 2012 – with its high number of new drug approvals, senior staff stability within the ... read more
Nov. 27, 2012 – An Oct. 31 enforcement letter from the FDA’s Office of Prescription Drug Promotion (OPDP) to Cornerstone ... read more
Feb. 23, 2012 – At a White House meeting held today to unveil the blueprint for the Obama Administration’s “Consumer ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication July 18, 2011 — For those who have not read the ... read more
July 12,
2012 – In a July
12 entry on his DrugWonks.com blog, Center for Medicine in the Public Interest Co-founder and President Peter Pitts discusses how Eli Lilly & Co. is using social media to its advantage. This example is significant, because many pharmaceutical companies continue to struggle with how – and how much – to involve social media in their promotional strategies.
Read more at: http://drugwonks.com/blog/a-little-guilding-of-the-eli-lilly
del.icio.us
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz
Recent Comments